Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial-Reference-Cited by-同舟云学术

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Published:2005-09 Issue:9 Volume:6 Page:649-658
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Berthold Frank,Boos Joachim,Burdach Stefan,Erttmann Rudolf,Henze Günter,Hermann Johann,Klingebiel Thomas,Kremens Bernhard,Schilling Freimut H,Schrappe Martin,Simon Thorsten,Hero Barbara

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. The role of autologous bone marrow transplantation in advanced neuroblastoma;Shuster;J Clin Oncol,1996

2. “Megatherapy” for advanced neuroblastoma—rationale and role;Pritchard;Eur J Cancer,1995

3. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry;Ladenstein;J Clin Oncol,1998

4. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma;Grupp;J Clin Oncol,2000

5. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study;Kletzel;J Clin Oncol,2002

Cited by 335 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response‐adapted consolidation therapy strategy for patients with metastatic high‐risk neuroblastoma: Results of the SMC NB‐2014 study;Pediatric Blood & Cancer;2024-07-04

2. Dual therapy of cancer using optimal control supported by swarm intelligence;Bio-Medical Materials and Engineering;2024-05-16

3. Immune reconstitution after transplantation of autologous peripheral stem cells in children: a comparison between CD34+ selected and nonmanipulated grafts;Cytotherapy;2024-05

4. A nationwide phase II study of delayed local treatment for children with high‐risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN‐H‐11;Pediatric Blood & Cancer;2024-04-05

5. Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma;Cancer Letters;2024-04